# Coreg and HSRs-Updated Analysis

> **NCT01316952** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Hypersensitivity

## Interventions

- **DRUG:** Carvedilol immediate release only
- **DRUG:** Carvedilol extended release only
- **DRUG:** Long acting β-blockers
- **DRUG:** Other α1/β-adrenergic antagonists
- **DRUG:** Short acting Non-selective β-blockers and short acting β1-Selective agents
- **OTHER:** No β-blocker

## Key facts

- **NCT ID:** NCT01316952
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316952, "Coreg and HSRs-Updated Analysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01316952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*